FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> Vaccine   HIV vaccine   AIDS vaccine   Merck
Syndicate content


Most Popular HIV/AIDS Story

Two new antibodies may lead to HIV/AIDS vaccine

Federal researchers have discovered two antibodies that may bring about the renaissance of HIV and AIDS treatment. The antibodies, VRC01 and VRC02, can kill up to 90 percent of HIV strains, compared Read more...

HIV/AIDS Press Releases

  • Phase III Clinical Trial of Gilead's Investigational Elvitegravir Meets 48-Week Primary Objective
  • Asian efforts in AIDS vaccine development step up
  • AVAC Calls for AIDS Vaccine Field to Implement New Scientific Strategic Plan Released by Global HIV Vaccine Enterprise
  • Has HIV Become More Virulent?
  • Avexa Limited Reports Positive 96 Week Data for HIV Drug Apricitabine (ATC)

Latest Headlines